End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2.31 USD | +4.05% |
|
+4,826.94% | -.--% |
05-13 | SurgePays Q1 Earnings, Revenue Fall | MT |
05-13 | Transcript : SurgePays, Inc., Q1 2024 Earnings Call, May 13, 2024 |
Sales 2024 * | 100M 7.89B | Sales 2025 * | 120M 9.43B | Capitalization | 68.52M 5.39B |
---|---|---|---|---|---|
Net income 2024 * | - 0 | Net income 2025 * | 14M 1.1B | EV / Sales 2024 * | 0.24 x |
Net cash position 2024 * | 44.93M 3.53B | Net cash position 2025 * | 55.29M 4.35B | EV / Sales 2025 * | 0.11 x |
P/E ratio 2024 * |
706
x | P/E ratio 2025 * |
5.01
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 68.94% |
Latest transcript on SURGEPAYS
1 day | +4.05% |
Managers | Title | Age | Since |
---|---|---|---|
Kevin Cox
CEO | Chief Executive Officer | 48 | 25/07/17 |
Anthony Evers
DFI | Director of Finance/CFO | 60 | 30/04/20 |
John Mott
CTO | Chief Tech/Sci/R&D Officer | - | 31/12/16 |
Members of the board | Title | Age | Since |
---|---|---|---|
David Keys
BRD | Director/Board Member | 68 | 16/07/19 |
Laurie Weisberg
BRD | Director/Board Member | 55 | 18/12/22 |
Kevin Cox
CEO | Chief Executive Officer | 48 | 25/07/17 |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+13.81% | 205B | |
+6.31% | 169B | |
+5.24% | 121B | |
-15.50% | 77.47B | |
+16.58% | 68.6B | |
-0.70% | 52.63B | |
-8.66% | 48.62B | |
-28.57% | 39.99B | |
-19.04% | 37.65B |
- Stock Market
- Equities
- SURG Stock
- SURG Stock